asp3662
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2014 (NCT02194491)
Timeline
Indications
Mechanism of action
HSD11B1 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- asp3662
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02372578 | Phase 2 | May 27, 2015 | Astellas |
| NCT02194491 | Phase 1 | Apr 1, 2014 | Astellas, Yale University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Astellas | For profit | 2 | 2 | 2 | 2014 |
| Yale University | Academic/Hospital | 1 | 0 | 1 | 2014 |
2 organizations
Page 1 / 1